Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Microchannel FT Reactor Technology Chosen for a Proposed BTL Project in Oregon

Published: Thursday, July 11, 2013
Last Updated: Thursday, July 11, 2013
Bookmark and Share
Velocys FT selected for construction of a commercial Biomass-to-Liquids plant in the USA.

The FT microchannel reactor technology developed by the Oxford Catalysts Group and marketed under the brand name Velocys, has been selected for use in the design and possible construction of a commercial Biomass-to-Liquids (BTL) plant in the USA.

The proposed BTL facility, led by Red Rock Biofuels, a subsidiary of the Fort Collins, Colorado, US-based company IR1 Group LLC, will be located in Oregon.

The plant will be designed to convert around 170,000 tons per year of forestry derived biomass into approximately 1,100 barrels per day (bpd) of liquid transportation fuels.

The Red Rock Biofuels BTL project was recently awarded a $4.1 million grant from the US Department of Defense (under the Defense Production Act Title III Advanced Drop-in Biofuel Production Project) to help to fund a detailed engineering and design study for the facility.

The preliminary engineering is complete. Now, with the aid of this grant, Red Rock Biofuels is expected to progress through detailed engineering and design over the course of nine months.

Following successful completion of the detailed design phase, IR1 Group will have an opportunity to apply for a further grant of up to $70 million to support construction of the proposed plant, and expects to do so.

Roy Lipski, CEO of Oxford Catalysts Group, said: “We are pleased to have our technology selected once again, this time for a promising opportunity in the growing area of Biomass-to-Liquids. We’re also excited by the potential for this project to access $70 million of government funding to support early adoption of a synthetic fuels plant.”

Terry Kulesa, CEO of IR1 Group, said: “The choice of Velocys FT was easy. No other FT technology offered the combination of high performance and efficiency at a scale appropriate for a BTL facility. We’re pleased to be working with the Group on this pioneering project.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Oxford Catalysts Selected for Design of 1,100 bpd BTL Plant
Company has been selected as the Fischer-Tropsch (FT) technology provider for the design and possible construction of a commercial Biomass-to-Liquids (BTL) plant.
Monday, July 08, 2013
Scientific News
Wrapping up the Genome
Researchers successfully package complete yeast genome using purified components, yielding new insights into genome mechanisms.
Enlisting Insects to Protect Agriculture
New program aims for insect delivery of protective genes to modify mature plants within a single growing season.
New Mechanism of Plant RNA Degradation Identified
Researchers have identified a novel mechanism by which RNA is degraded.
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
New Model for Understanding Human Myeloma
Researchers develop mouse model where mice carry six human genes involved in human tumour growth.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Ethical Challenges of Genome Editing
A review of bioethics idnetifies two top challenges for genome editing.
Genetically Engineered Crops Are Safe
Study finds genetically engineered crop's risk to human health and the environment are no different than conventional crops.
Nimbolide Could Suppress Prostate Cancer Development
Oral administration of nimbolide over 12 weeks shows reduction of prostate tumour size and decrease in tumour metastasis.
Modified Yeast Shows Plant Response to Key Hormone
Researchers have developed a toolkit based on modified yeast to determine plant responses to auxin.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos